Susceptibility in vitro of Epstein-Barr Virus to myristoylated-peptide

Peptides

Volumn 31, Issue 7, 2010, Pages 1409-1411

  Ourth, Donald D ^a  

^a University of Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DOUBLE STRANDED DNA; GANCICLOVIR; INSECT PROTEIN; PEPTIDE;

AMINO TERMINAL SEQUENCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA SYNTHESIS INHIBITION; DRUG CYTOTOXICITY; DRUG ISOLATION; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; HUMAN CELL; INSECT; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELLS, CULTURED; DNA, VIRAL; FIBROBLASTS; HERPESVIRUS 4, HUMAN; HUMANS; LIPOPEPTIDES; PEPTIDES; VIRAL MATRIX PROTEINS;

DNA VIRUSES; HELIOTHIS VIRESCENS; HERPESVIRIDAE; HEXAPODA; HUMAN HERPESVIRUS 4;

EID: 77952553668     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.03.031     Document Type: Article

References (9)

1. Cohen J.I. Epstein-Barr Virus infection. N Engl J Med 343 (2000) 481-492
2. Drew W.L. Herpesviruses. In: Ryan K.J., and Ray C.G. (Eds). Sherris medical microbiology. 4th ed. (2004), McGraw-Hill, New York, NY 555-576
3. Jenson H.B. Epstein-Barr Virus. In: Kliegman R.M., et al. (Ed). Nelson textbook of pediatrics. 18th ed. (2007), Saunders Elsevier, Philadelphia, PA 1372-1377
4. Komano J., and Takada K. Role of bci-2 in Epstein-Barr Virus-induced malignant conversion of Burkitt's lymphoma cell line Akata. J Virol 75 (2001) 1561-1564
5. Ourth D.D. Antiviral activity against human immunodeficiency virus-1 in vitro by myristoylated-peptide from Heliothis virescens. Biochem Biophys Res Commun 320 (2004) 190-196
6. Ourth D.D., and Renis H.E. Antiviral melanization reaction of Heliothis virescens hemolymph against DNA and RNA viruses in vitro. Comp Biochem Physiol 105B (1993) 719-723
7. Rowe M., Young L.S., Crocker J., Stokes H., Henderson S., and Rickinson A.B. Epstein-Barr Virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173 (1991) 147-158
8. Shimizu N., Tanabe-Tochikura A., Kuroiwa Y., and Takada K. Isolation of Epstein-Barr Virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) cell line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 68 (1994) 6069-6073
9. Shimizu N., Yoshiyama H., and Takada K. Clonal propagation of Epstein-Barr Virus (EBV) recombinants in EBV-negative Akata cells. J Virol 70 (1996) 7260-7263